abstract |
The present invention relates to a procoagulant fusion protein, a polynucleotide encoding the fusion protein, and a cell expressing the fusion protein. Furthermore, the present invention relates to a fusion protein for use as a medicament. Individuals with coagulation disorders such as inhibitor-bearing or non-bearing hemophilia A and B can be treated with the fusion proteins of the invention. |